PRECIGEN, INC. Due to Related Parties, Current
PRECIGEN, INC. (PGEN) had Due to Related Parties, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Notes
us-gaap:DueToRelatedPartiesCurrent · last filed 2023-03-06
- 2022-12-31: Due to Related Parties, Current $0.00.
- 2022-09-30: Due to Related Parties, Current $0.00.
- 2022-06-30: Due to Related Parties, Current $58.00K.
- 2022-03-31: Due to Related Parties, Current $26.00K.
| Period end | Due to Related Parties, Current | Due to Related Parties, Current as first filed |
|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-06 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $58.00K 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $26.00K 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $74.00K 10-K · filed 2023-03-06 | $27.00K 10-K · filed 2022-03-01 |
| 2021-09-30 | $23.00K 10-Q · filed 2021-11-08 | |
| 2021-06-30 | $22.00K 10-Q · filed 2021-08-09 | |
| 2021-03-31 | $52.00K 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $19.00K 10-K · filed 2022-03-01 | |
| 2020-09-30 | $357.00K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $175.00K 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $139.00K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $51.00K 10-K · filed 2021-03-01 | |
| 2019-09-30 | $44.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $74.00K 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $2.17M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $256.00K 10-K · filed 2020-03-02 | |
| 2018-09-30 | $143.00K 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $112.00K 10-Q · filed 2018-08-13 | |
| 2018-03-31 | $147.00K 10-Q/A · filed 2018-08-13 | |
| 2017-12-31 | $313.00K 10-K · filed 2019-03-01 | |
| 2017-09-30 | $816.00K 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $744.00K 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $621.00K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $440.00K 10-K · filed 2018-03-01 | |
| 2016-09-30 | $611.00K 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $456.00K 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $358.00K 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $150.00K 10-K · filed 2017-03-01 | |
| 2015-09-30 | $147.00K 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $57.58M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $52.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $214.00K 10-K · filed 2016-02-29 | |
| 2014-09-30 | $1.16M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $95.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $58.00K 10-Q · filed 2014-05-09 | |
| 2013-12-31 | $1.60M 10-K · filed 2015-03-02 | |
| 2013-09-30 | $5.13M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $10.00K 10-Q/A · filed 2013-10-21 | |
| 2012-12-31 | $99.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |